AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $531,164 | -2.7% | 7,600 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $546,136 | +38.3% | 7,600 | +18.8% | 0.00% | +100.0% |
Q1 2023 | $394,752 | -44.4% | 6,400 | -30.4% | 0.00% | -50.0% |
Q4 2022 | $709,519 | -79.0% | 9,199 | -87.9% | 0.00% | -78.9% |
Q3 2022 | $3,384,000 | +164.8% | 75,833 | +127.3% | 0.02% | +137.5% |
Q2 2022 | $1,278,000 | +67.3% | 33,368 | +80.7% | 0.01% | +33.3% |
Q1 2022 | $764,000 | -28.3% | 18,466 | -34.5% | 0.01% | -40.0% |
Q4 2021 | $1,065,000 | -31.6% | 28,191 | -40.4% | 0.01% | -50.0% |
Q3 2021 | $1,558,000 | +63.5% | 47,284 | +181.1% | 0.02% | +66.7% |
Q1 2021 | $953,000 | +386.2% | 16,823 | +598.0% | 0.01% | +300.0% |
Q4 2020 | $196,000 | +30.7% | 2,410 | +14.5% | 0.00% | +50.0% |
Q3 2020 | $150,000 | -65.9% | 2,104 | -60.6% | 0.00% | -75.0% |
Q2 2020 | $440,000 | +140.4% | 5,345 | +72.0% | 0.01% | +60.0% |
Q1 2020 | $183,000 | -91.0% | 3,108 | -84.2% | 0.01% | -86.5% |
Q4 2019 | $2,035,000 | +2161.1% | 19,686 | +344.8% | 0.04% | +1750.0% |
Q3 2019 | $90,000 | -77.4% | 4,426 | -71.5% | 0.00% | -71.4% |
Q2 2019 | $399,000 | – | 15,509 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |